Delta Financial Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$246K Hold
2,219
0.06% 218
2024
Q4
$216K Hold
2,219
0.05% 230
2024
Q3
$255K Hold
2,219
0.09% 112
2024
Q2
$236K Buy
2,219
+5
+0.2% +$502 0.1% 106
2024
Q1
$214K Buy
2,214
+44
+2% +$4.51K 0.06% 213
2023
Q4
$219K Sell
2,170
-3
-0.1% -$290 0.07% 200
2023
Q3
$221K Buy
2,173
+145
+7% +$14.7K 0.08% 184
2023
Q2
$205K Buy
+2,028
New +$203K 0.24% 79

Other funds holding NVS

Delta Financial Group's NVS Position: Q1 2025 in Review

Delta Financial Group held its Novartis (NVS) position steady in Q1 2025 at 2,219 shares worth $246K. The position accounts for 0.06% of the portfolio, ranked #218.

Delta Financial Group first reported a position in NVS in Q2 2023 and has held it in 8 quarters since. The position peaked at $255K in Q3 2024. 1,356 funds tracked by Wall St. Rank hold NVS as of Q1 2025.

  • Delta Financial Group held 2,219 shares of Novartis worth $246K as of Q1 2025.
  • Delta Financial Group left its Novartis share count unchanged in Q1 2025.
  • Novartis made up 0.06% of Delta Financial Group's portfolio in Q1 2025, its #218 holding.
  • Delta Financial Group first reported a position in Novartis in Q2 2023 and has held it in 8 quarters since.
  • Delta Financial Group's Novartis position peaked at $255K in Q3 2024.
  • 1,356 funds tracked by Wall St. Rank held Novartis as of Q1 2025.

Based on Delta Financial Group's 13F filing for Q1 2025, filed 9 May 2025.